在印度梅加拉亚州的哈西人中,喘的环境决定因素
Prabhnoor Saini1, Baname W D Waanbah2, N K Mungreiphy1
1Department of Anthropology, AISS, Amity University Uttar Pradesh, Noida, India.
概括
环境因素显著增加了Khasi社区的喘风险. 缺乏阳光,被动烟草烟雾和生物质燃料暴露是关键因素,突显了公共卫生干预的必要性.
科学领域:
- 环境健康 环境健康
- 流行病学 流行病学
- 肺部病理学 肺部病理学
背景情况:
- 喘是一种普遍存在的阻塞性呼吸道疾病,具有显著的发病率和死亡率.
- 像哈西人这样的土著人口由于环境暴露而表现出更高的喘易感性.
- 了解特定的环境决定因素对于针对弱势社区的有针对性的干预至关重要.
研究的目的:
- 调查在梅加拉亚州Khasi人口中导致喘风险的环境因素.
- 确定与本土社区喘相关的特定室内,室外和工作场所环境暴露.
主要方法:
- 一项涉及249例喘病例和252例来自印度梅加拉雅的卡西社区的对照病例和对照病例的研究.
- 通过验证的采访计划收集数据,评估环境暴露.
- 使用IBM SPSS (v26) 进行统计分析,以确定环境因素与喘之间的关联 (p < 0.05时的显著性).
主要成果:
- 缺乏阳光与喘风险增加有很强的关联 (调整几率比率[AOR] = 43.12,p < 0.001).
- 显著的危险因素包括早期被动烟草烟雾暴露 (AOR = 12.81,p < 0.001),传统生物质燃料使用 (AOR = 8.72,p < 0.001) 和烟 (AOR = 3.76,p < 0.01).
- 暴露于汽车烟雾与喘风险增加了三倍 (AOR = 2.97,p < 0.01).
结论:
- 环境因素对卡西族社区中喘患病率有很大影响.
- 公共卫生战略应侧重于改善住房,减少来自生物质燃料和烟雾的室内空气污染,并减轻室外环境风险.
- 有针对性的干预措施对于解决该人口中喘的环境决定因素至关重要.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management
623
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
623
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
490
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
490
Asthma-III: Symptoms and Complications
2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.7K


